Skip to main content
Top
Published in: Diabetologia 12/2011

01-12-2011 | Short Communication

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study

Authors: R. M. Anjana, R. Pradeepa, M. Deepa, M. Datta, V. Sudha, R. Unnikrishnan, A. Bhansali, S. R. Joshi, P. P. Joshi, C. S. Yajnik, V. K. Dhandhania, L. M. Nath, A. K. Das, P. V. Rao, S. V. Madhu, D. K. Shukla, T. Kaur, M. Priya, E. Nirmal, S. J. Parvathi, S. Subhashini, R. Subashini, M. K. Ali, V. Mohan, on behalf of the ICMR–INDIAB Collaborative Study Group

Published in: Diabetologia | Issue 12/2011

Login to get access

Abstract

Aims/hypothesis

This study reports the results of the first phase of a national study to determine the prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in India.

Methods

A total of 363 primary sampling units (188 urban, 175 rural), in three states (Tamilnadu, Maharashtra and Jharkhand) and one union territory (Chandigarh) of India were sampled using a stratified multistage sampling design to survey individuals aged ≥20 years. The prevalence rates of diabetes and prediabetes were assessed by measurement of fasting and 2 h post glucose load capillary blood glucose.

Results

Of the 16,607 individuals selected for the study, 14,277 (86%) participated, of whom 13,055 gave blood samples. The weighted prevalence of diabetes (both known and newly diagnosed) was 10.4% in Tamilnadu, 8.4% in Maharashtra, 5.3% in Jharkhand, and 13.6% in Chandigarh. The prevalences of prediabetes (impaired fasting glucose and/or impaired glucose tolerance) were 8.3%, 12.8%, 8.1% and 14.6% respectively. Multiple logistic regression analysis showed that age, male sex, family history of diabetes, urban residence, abdominal obesity, generalised obesity, hypertension and income status were significantly associated with diabetes. Significant risk factors for prediabetes were age, family history of diabetes, abdominal obesity, hypertension and income status.

Conclusions/interpretations

We estimate that, in 2011, Maharashtra will have 6 million individuals with diabetes and 9.2 million with prediabetes, Tamilnadu will have 4.8 million with diabetes and 3.9 million with prediabetes, Jharkhand will have 0.96 million with diabetes and 1.5 million with prediabetes, and Chandigarh will have 0.12 million with diabetes and 0.13 million with prediabetes. Projections for the whole of India would be 62.4 million people with diabetes and 77.2 million people with prediabetes.
Literature
1.
go back to reference Anjana RM, Pradeepa R, Deepa M et al (2011) The Indian Council of Medical Research–India Diabetes (ICMR–INDIAB) Study: methodological details. J Diabetes Sci Technol 5:906–914PubMed Anjana RM, Pradeepa R, Deepa M et al (2011) The Indian Council of Medical Research–India Diabetes (ICMR–INDIAB) Study: methodological details. J Diabetes Sci Technol 5:906–914PubMed
2.
go back to reference International Institute for Population Sciences (IIPS) and Macro International (2007) National Family Health Survey (NFHS-3), 2005–06: India: volume II. IIPS, Mumbai International Institute for Population Sciences (IIPS) and Macro International (2007) National Family Health Survey (NFHS-3), 2005–06: India: volume II. IIPS, Mumbai
3.
go back to reference World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation, Geneva, World Health Organization, p 39 World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation, Geneva, World Health Organization, p 39
4.
go back to reference Population projections for India and States 2001–2026 (2006) Report of the technical group on population projections constituted by the National Commission on Population. Office of the Registrar General & Census Commissioner, New Delhi, India, pp 140–247 Population projections for India and States 2001–2026 (2006) Report of the technical group on population projections constituted by the National Commission on Population. Office of the Registrar General & Census Commissioner, New Delhi, India, pp 140–247
5.
go back to reference Ahuja MMS (1979) Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS (ed) Epidemiology of diabetes in developing countries. Interprint, New Delhi, pp 29–38 Ahuja MMS (1979) Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS (ed) Epidemiology of diabetes in developing countries. Interprint, New Delhi, pp 29–38
6.
go back to reference Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094–1101PubMedCrossRef Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094–1101PubMedCrossRef
7.
go back to reference Sadikot SM, Nigam A, Das S et al (2004) The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: Prevalence of Diabetes in India Study (PODIS). Diabetes Res Clin Pract 66:301–307PubMedCrossRef Sadikot SM, Nigam A, Das S et al (2004) The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: Prevalence of Diabetes in India Study (PODIS). Diabetes Res Clin Pract 66:301–307PubMedCrossRef
8.
go back to reference Ravikumar P, Bhansali A, Ravikiran M et al (2010) Prevalence and risk factors of diabetes in a community-based study in North India: the Chandigarh Urban Diabetes Study (CUDS). Diabetes Metab 37:216–221PubMedCrossRef Ravikumar P, Bhansali A, Ravikiran M et al (2010) Prevalence and risk factors of diabetes in a community-based study in North India: the Chandigarh Urban Diabetes Study (CUDS). Diabetes Metab 37:216–221PubMedCrossRef
9.
go back to reference Mohan V, Deepa M, Deepa R et al (2006) Secular trends in the prevalence of diabetes and glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 49:1175–1178PubMedCrossRef Mohan V, Deepa M, Deepa R et al (2006) Secular trends in the prevalence of diabetes and glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 49:1175–1178PubMedCrossRef
10.
go back to reference Priya M, Anjana RM, Pradeepa R et al (2011) Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries. Diabetes Technol Ther 13:586–591PubMedCrossRef Priya M, Anjana RM, Pradeepa R et al (2011) Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries. Diabetes Technol Ther 13:586–591PubMedCrossRef
Metadata
Title
Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study
Authors
R. M. Anjana
R. Pradeepa
M. Deepa
M. Datta
V. Sudha
R. Unnikrishnan
A. Bhansali
S. R. Joshi
P. P. Joshi
C. S. Yajnik
V. K. Dhandhania
L. M. Nath
A. K. Das
P. V. Rao
S. V. Madhu
D. K. Shukla
T. Kaur
M. Priya
E. Nirmal
S. J. Parvathi
S. Subhashini
R. Subashini
M. K. Ali
V. Mohan
on behalf of the ICMR–INDIAB Collaborative Study Group
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2291-5

Other articles of this Issue 12/2011

Diabetologia 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine